chevron_leftBack
As of 12 July 2026, Chong Kun Dang Pharmaceutical Corp. has a market cap of $749.79M USD, ranking #12459 globally and #321 in South Korea.
It ranks #1142 in the Healthcare sector, and #424 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$749.79MUSD
1.13T KRW
Enterprise Value
$769.17MUSD
1.15T KRW
Revenue (TTM)
$1.12BUSD
1.69T KRW
EBITDA (TTM)
$83.63MUSD
125.37B KRW
Net Income (TTM)
$51.47MUSD
77.51B KRW
EBITDA Margin
7.4%
Profit Margin
4.6%
PE Ratio
14.7
Forward PE
15.8
PS Ratio
0.7
PB Ratio
1.1
EV/EBITDA
9.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Young-Joo Kim
open_in_new
Employees
2,253
Founded
1941
Website
ckdpharm.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.4% | -0.7% | -5.6% | -0.3% | 4% | 10% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
185750
(주)종근당
ISIN: KR7185750007
Shares Out.:
Shares Outstanding:
13.176M1
Shares Float:
6.613M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
85,700 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Chong Kun Dang Pharmaceutical Corp.
Chong Kun Dang Pharmaceutical Corp. manufactures, markets, and sells medicines in South Korea and internationally. It offers prescription drugs for anti-hypertension, anti-hyperlipidaemia, and anti-diabetics, as well as immunosuppressants; over-the-counter medicines; and consumer health products, such as insecticides and hair dye products, as well as health supplements. The company was founded in 1941 and is headquartered in Seoul, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 0126Z0
|
$9.24B
1K%
13.91T KRW
|
-
|
|
KRX: 326030
|
$5.29B
606%
7.97T KRW
|
29.9
|
|
KRX: 298380
|
$5.01B
568%
7.55T KRW
|
-
|
|
KRX: 000100
|
$4.6B
513%
6.92T KRW
|
35.9
|
|
KRX: 141080
|
$4.49B
498%
6.76T KRW
|
-
|
|
KRX: 128940
|
$4.07B
442%
6.12T KRW
|
36.1
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
101K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
73K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
48K%
|
97.4
|
|
SIX: RO
|
$317.7B
42K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.23B
38K%
215.59B GBP
|
27.6
|
|
NYSE: MRK
|
$274.03B
36K%
|
15.1
|
chevron_leftBack